Tango Therapeutics, Inc. (TNGX)

Typically moves ±8.75% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-05 APPROXIMATE

Across 20 earnings reports since Nov 09, 2021, Tango Therapeutics, Inc. (TNGX) has a clear post-earnings pattern. It moves ±8.75% on average after reporting and finishes higher 55.0% of the time. Its largest post-earnings gain was +36.28% (Mar 05, 2026) and its largest decline was -37.45% (Nov 06, 2024). The next earnings report is predicted for 2026-11-05 (approximate).

Earnings reactions

How TNGX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±8.75%

Positive %

55.0%

Negative %

45.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 11, 2026	☀ PRE	-4.91%	open_in_new
May 13, 2026	☽ POST	-2.39%	open_in_new
Mar 05, 2026	☀ PRE	+36.28%	open_in_new
Nov 04, 2025	☀ PRE	+0%	open_in_new
Aug 05, 2025	☀ PRE	+4.86%	open_in_new
May 12, 2025	☀ PRE	+14.91%	open_in_new
Feb 27, 2025	☀ PRE	-6.44%	open_in_new
Nov 06, 2024	☀ PRE	-37.45%	open_in_new
Aug 07, 2024	☀ PRE	-3.22%	open_in_new
May 08, 2024	☀ PRE	+0.76%	open_in_new
Mar 18, 2024	☀ PRE	-7.09%	open_in_new
Nov 08, 2023	☀ PRE	+3.83%	open_in_new
Aug 07, 2023	☀ PRE	+1.18%	open_in_new
May 09, 2023	☀ PRE	+6.4%	open_in_new
Mar 27, 2023	☀ PRE	-9.35%	open_in_new
Nov 10, 2022	☀ PRE	-5.27%	open_in_new
Aug 10, 2022	☀ PRE	+22.41%	open_in_new
May 11, 2022	☀ PRE	-7.57%	open_in_new
Mar 28, 2022	☀ PRE	+0.29%	open_in_new
Nov 09, 2021	☀ PRE	+0.4%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±8.75%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 26 →

Funds holding

$1289689376

Total value held

Buying

24 added · 1 reduced

Blackrock, Inc.

$388825760 +42.19%

Goldman Sachs Group Inc

$311994191 +96.61%

State Street Corp

$186928736 +28.55%

Jefferies Financial Group Inc.

$62849293 NEW BUY

Franklin Resources Inc

$58994217 +45.59%

SEC Filing Types

description SCHEDULE 13G/A

description SCHEDULE 13G

11 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260903	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260812	open_in_new SEC.gov
10-Q	20260811	open_in_new SEC.gov
424B5	20260811	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov

Frequently asked about TNGX earnings

When does Tango Therapeutics, Inc. report earnings next? expand_more

Tango Therapeutics, Inc. (TNGX)'s next earnings date is approximate for 2026-11-05. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does TNGX stock move after earnings? expand_more

Over 20 reports, TNGX has moved an average of ±8.75% the session after earnings, closing higher 55.0% of the time.

What was TNGX's biggest post-earnings move? expand_more

TNGX's largest post-earnings gain on record was +36.28% on Mar 05, 2026, and its largest decline was -37.45% on Nov 06, 2024.

Where can I find Tango Therapeutics, Inc.'s SEC filings? expand_more

All of Tango Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.